Study of DA-9501 In Pediatric Subjects In The Intensive Care Unit
Status:
Completed
Trial end date:
2017-05-24
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy, safety, and pharmacokinetics of dexmedetomidine given as continuous
IV infusion in pediatric subjects [≥ 45 weeks CGA (corrected gestational age) to <17 years
old] requiring sedation under intensive care unit